Live attenuated influenza vaccine tetravalent: a clinical review

References

• Nair H, Brooks WA, Katz M, et al. Global burden of respiratory infections due to seasonal influenza in young children: a systematic review and meta-analysis. Lancet 2011;378(9807):1917-30
   PubMed Web of Science ®Google Scholar
• Cromer D, van Hoek AJ, Jit M, et al. The burden of influenza in England by age and clinical risk group: a statistical analysis to inform vaccine policy. J Infect 2014;68(4):363-71
   PubMed Web of Science ®Google Scholar
• Heikkinen T, Ikonen N, Ziegler T. Impact of influenza B lineage-level mismatch between trivalent seasonal influenza vaccines and circulating viruses, 1999-2012. Clin Infect Dis 2014;59(11):1519-24
   PubMed Web of Science ®Google Scholar
• Belshe RB, Coelingh K, Ambrose CS, et al. Efficacy of live attenuated influenza vaccine in children against influenza B viruses by lineage and antigenic similarity. Vaccine 2010;28(9):2149-56
   PubMed Web of Science ®Google Scholar
• Heikkinen T, Silvennoinen H, Peltola V, et al. Burden of influenza in children in the community. J Infect Dis 2004;190(8):1369-73
   PubMed Web of Science ®Google Scholar
• Poehling KA, Edwards KM, Weinberg GA, et al. The underrecognized burden of influenza in young children. N Engl J Med 2006;355(1):31-40
   PubMed Web of Science ®Google Scholar
• Prevention and control of influenza. MMWR Morb Mortal Wkly Rep 2000;49:1-38
   PubMedGoogle Scholar
• Esposito S, Cantarutti L, Molteni CG, et al. Clinical manifestations and socio-economic impact of influenza among healthy children in the community. J Infect 2011;62(5):379-87
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. Estimated influenza illnesses and hospitalizations averted by influenza vaccination - United States, 2012-13 influenza season. MMWR Morb Mortal Wkly Rep 2013;62(49):997-1000
   Google Scholar
• Centers for Disease Control and Prevention. Influenza activity - United States, 2012-13 season and composition of the 2013-14 influenza vaccine. MMWR Morb Mortal Wkly Rep 2013;62:473-9
   PubMed Web of Science ®Google Scholar
• Chi XS, Bolar TV, Zhao P, et al. Cocirculation and evolution of two lineages of influenza B viruses in Europe and Israel in the 2001-2002 season. J Clin Microbiol 2003;41(12):5770-3
   Google Scholar
• World Health Organization. Recommended composition of influenza virus vaccines for use in the 2011-2012 northern hemisphere influenza season. Wkly Epidemiol Rec 2011;86(10):86-90
   Google Scholar
• Ambrose CS, Levin MJ. The rationale for quadrivalent influenza vaccines. Hum Vaccin Immunother 2012;8(1):81-8
   PubMed Web of Science ®Google Scholar
• Monto AS, Ansaldi F, Aspinall R, et al. Influenza control in the 21st century: optimizing protection of older adults. Vaccine 2009;27(37):5043-53
   PubMed Web of Science ®Google Scholar
• Hite LK, Glezen WP, Demmler GJ, Munoz FM. Medically attended pediatric influenza during the resurgence of the Victoria lineage of influenza B virus. Int J Infect Dis 2007;11(1):40-7
   PubMed Web of Science ®Google Scholar
• Peltola V, Ziegler T, Ruuskanen O. Influenza A and B virus infections in children. Clin Infect Dis 2003;36:299-305
   PubMed Web of Science ®Google Scholar
• Shen CF, Huang SC, Wang SM, et al. Decreased leukocytes and other characteristics of laboratory findings of influenza virus infections in children. J Microbiol Immunol Infect 2008;41(4):294-300
   Google Scholar
• Centers for Disease Control and Prevention. Update: influenza activity – United States, 2010–11 season, and composition of the 2011-12 influenza vaccine. MMWR Morb Mortal Wkly Rep 2011;60:705-12
   Google Scholar
• Glezen WP, Schmier JK, Kuehn CM, et al. The burden of influenza B: a structured literature review. Am J Public Health 2013;103(3):e43-51
   Web of Science ®Google Scholar
• Silva ML, Perrier L, Spath HM, et al. Economic burden of seasonal influenza B in France during winter 2010-2011. BMC Public Health 2014;14:56
   PubMed Web of Science ®Google Scholar
• Grohskopf LA, Olsen SJ, Sokolow LZ, et al. Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP) - United States, 2014-15 influenza season. MMWR Morb Mortal Wkly Rep 2014;63(32):691-7
   PubMed Web of Science ®Google Scholar
• Pebody RG, Green HK, Andrews N, et al. Uptake and impact of a new live attenuated influenza vaccine programme in England: early results of a pilot in primary school-age children, 2013/14 influenza season. Euro Surveill 2014;19:pii 20823
   Google Scholar
• Centers for Disease Control and Prevention. Summary recommendations: prevention and control of influenza with vaccines: recommendations of the advisory committee on immunization practices -(ACIP)-United States, 2013-14. Available from: www.cdc.gov/flu/professionals/acip/2013-summary-recommendations.htm [Accessed 7 August 2014]
   Google Scholar
• European Centre for Disease Prevention and Control. Influenza vaccination. Available from: www.ecdc.europa.eu/en/healthtopics/seasonal_influenza/vaccines/pages/influenza_vaccination.aspx [Accessed 16 July 2013]
   Google Scholar
• Rose MA, Damm O, Greiner W, et al. The epidemiological impact of childhood influenza vaccination using live-attenuated influenza vaccine (LAIV) in Germany: predictions of a simulation study. BMC Infect Dis 2014;14:40
   PubMed Web of Science ®Google Scholar
• Bracco Neto H, Farhat CK, Tregnaghi MW, et al. Efficacy and safety of 1 and 2 doses of live attenuated influenza vaccine in vaccine-naive children. Pediatr Infect Dis J 2009;28(5):365-71
   Google Scholar
• Tam JS, Capeding MR, Lum LC, et al. Efficacy and safety of a live attenuated, cold-adapted influenza vaccine, trivalent against culture-confirmed influenza in young children in Asia. Pediatr Infect Dis J 2007;26(7):619-28
   PubMed Web of Science ®Google Scholar
• Vesikari T, Fleming DM, Aristegui JF, et al. Safety, efficacy, and effectiveness of cold-adapted influenza vaccine-trivalent against community-acquired, culture-confirmed influenza in young children attending day care. Pediatrics 2006;118(6):2298-312
   PubMed Web of Science ®Google Scholar
• Heikkinen T, Block SL, Toback SL, et al. Effectiveness of intranasal live attenuated influenza vaccine against all-cause acute otitis media in children. Pediatr Infect Dis J 2013;32(6):669-74
   PubMedGoogle Scholar
• Jefferson T, Rivetti A, Di Pietrantonj C, et al. Vaccines for preventing influenza in healthy children. Cochrane Database Syst Rev 2012;8:CD004879
   PubMed Web of Science ®Google Scholar
• Osterholm MT, Kelley NS, Sommer A, Belongia EA. Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis. Lancet Infect Dis 2012;12(1):36-44
   PubMed Web of Science ®Google Scholar
• Belshe RB, Edwards KM, Vesikari T, et al. Live attenuated versus inactivated influenza vaccine in infants and young children. N Engl J Med 2007;356(7):685-96
   PubMed Web of Science ®Google Scholar
• Ashkenazi S, Vertruyen A, Aristegui J, et al. Superior relative efficacy of live attenuated influenza vaccine compared with inactivated influenza vaccine in young children with recurrent respiratory tract infections. Pediatr Infect Dis J 2006;25(10):870-9
   PubMed Web of Science ®Google Scholar
• Fleming DM, Crovari P, Wahn U, et al. Comparison of the efficacy and safety of live attenuated cold-adapted influenza vaccine, trivalent, with trivalent inactivated influenza virus vaccine in children and adolescents with asthma. Pediatr Infect Dis J 2006;25(10):860-9
   PubMed Web of Science ®Google Scholar
• Ambrose CS, Yi T, Walker RE, Connor EM. Duration of protection provided by live attenuated influenza vaccine in children. Pediatr Infect Dis J 2008;27(8):744-8
   Google Scholar
• Belshe RB, Toback SL, Yi T, Ambrose CS. Efficacy of live attenuated influenza vaccine in children 6 months to 17 years of age. Influenza Other Respir Viruses 2010;4(3):141-5
   Google Scholar
• Block SL, Falloon J, Hirschfield JA, et al. Immunogenicity and safety of a quadrivalent live attenuated influenza vaccine in children. Pediatr Infect Dis J 2012;31(7):745-51
   PubMed Web of Science ®Google Scholar
• FluMist^®, Quadrivalent (Influenza Virus Vaccine Live, Intranasal). Full prescribing information. MedImmune; Gaithersburg, MD: 2014
   Google Scholar
• King JCJr, Treanor J, Fast PE, et al. Comparison of the safety, vaccine virus shedding, and immunogenicity of influenza virus vaccine, trivalent, types A and B, live cold-adapted, administered to human immunodeficiency virus (HIV)-infected and non-HIV-infected adults. J Infect Dis 2000;181(2):725-8
   PubMed Web of Science ®Google Scholar
• Levin MJ, Song LY, Fenton T, et al. Shedding of live vaccine virus, comparative safety, and influenza-specific antibody responses after administration of live attenuated and inactivated trivalent influenza vaccines to HIV-infected children. Vaccine 2008;26(33):4210-17
   PubMed Web of Science ®Google Scholar
• Halasa N, Englund JA, Nachman S, et al. Safety of live attenuated influenza vaccine in mild to moderately immunocompromised children with cancer. Vaccine 2011;29(24):4110-15
   Google Scholar
• European Medicines Agency. Fluenz: EPAR- Product Information. Available from: www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/001101/WC500103709.pdf [Accessed 5 August 2014]
   Google Scholar
• Paget WJ, Balderston C, Casas I, et al. Assessing the burden of paediatric influenza in Europe: the European Paediatric Influenza Analysis (EPIA) project. Eur J Pediatr 2010;169(8):997-1008
   PubMed Web of Science ®Google Scholar
• von Kries R, Weiss S, Falkenhorst G, et al. Post-pandemic seroprevalence of pandemic influenza A (H1N1) 2009 infection (swine flu) among children <18 years in Germany. PLoS One 2011;6(9):e23955
   Google Scholar
• Izurieta HS, Thompson WW, Kramarz P, et al. Influenza and the rates of hospitalization for respiratory disease among infants and young children. N Engl J Med 2000;342(4):232-9
   PubMed Web of Science ®Google Scholar
• Neuzil KM, Mellen BG, Wright PF, et al. The effect of influenza on hospitalizations, outpatient visits, and courses of antibiotics in children. N Engl J Med 2000;342(4):225-31
   PubMed Web of Science ®Google Scholar
• Weigl JA, Puppe W, Schmitt HJ. The incidence of influenza-associated hospitalizations in children in Germany. Epidemiol Infect 2002;129(3):525-33
   PubMed Web of Science ®Google Scholar
• Shaw MW, Xu X, Li Y, et al. Reappearance and global spread of variants of influenza B/Victoria/2/87 lineage viruses in the 2000-2001 and 2001-2002 seasons. Virology 2002;303(1):1-8
   PubMedGoogle Scholar
• Thompson WW, Shay DK, Weintraub E, et al. Influenza-associated hospitalizations in the United States. JAMA 2004;292(11):1333-40
   PubMed Web of Science ®Google Scholar
• Thompson WW, Shay DK, Weintraub E, et al. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA 2003;289(2):179-86
   PubMed Web of Science ®Google Scholar
• Reed C, Meltzer MI, Finelli L, Fiore A. Public health impact of including two lineages of influenza B in a quadrivalent seasonal influenza vaccine. Vaccine 2012;30(11):1993-8
   PubMed Web of Science ®Google Scholar
• European Centre for Disease Prevention and Control. Review of the scientific literature on drivers and barriers of seasonal influenza coverage in the EU/EEA. Available from: www.ecdc.europa.eu/en/publications/Publications/seasonal-influenza-vaccination-drivers-barriers.pdf [Accessed 7 August 2014]
   Google Scholar
• State of Israel Ministry of Health. Vaccine against influenza in healthy children and pregnant women. Available from: www.health.gov.il/English/Topics/Pregnancy/Vaccination_of_infants/Pages/flu.aspx [Accessed June 2014]
   Google Scholar
• Public Health Agency of Canada. Revised wording to the National Advisory Committee on Immunization (NACI) recommendation for live attenuated influenza vaccine (LAIV) in healthy children and adolescents 2-17 years of age. Available from: www.phac-aspc.gc.ca/publicat/ccdr-rmtc/13vol39/acs-dcc-4/rev-eng.php [Accessed 22 September 2014]
   Google Scholar
• Falkenhorst G, Harder T, Remschmidt C, et al. Background paper to the recommendation for the preferential use of live-attenuated influenza vaccine in children aged 2-6 years in Germany. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2013;56(11):1557-64
   Google Scholar
• Forrest BD, Pride MW, Dunning AJ, et al. Correlation of cellular immune responses with protection against culture-confirmed influenza virus in young children. Clin Vaccine Immunol 2008;15(7):1042-53
   PubMed Web of Science ®Google Scholar
• Lum LC, Borja-Tabora CF, Breiman RF, et al. Influenza vaccine concurrently administered with a combination measles, mumps, and rubella vaccine to young children. Vaccine 2010;28(6):1566-74
   Google Scholar
• Belshe RB, Mendelman PM, Treanor J, et al. The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine in children. N Engl J Med 1998;338(20):1405-12
   PubMed Web of Science ®Google Scholar
• Belshe RB, Gruber WC, Mendelman PM, et al. Efficacy of vaccination with live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine against a variant (A/Sydney) not contained in the vaccine. J Pediatr 2000;136(2):168-75
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. Past Weekly Surveillance Reports. Available from: www.cdc.gov/flu/weekly/pastreports.htm [Accessed 10 October 2011]
   Google Scholar
• Organization ECfDPaCaWH. Flu News Europe. 2014. Available from: www.flunewseurope.org/
   Google Scholar
• Available from: http://www.nivel.nl/sites/default/files/bestanden/Annual-Report-2006-2007-EISS-nivel-logo.pdf
   Google Scholar